The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Hemostatic & Tissue Sealants-Global Market Insights and Sales Trends 2024

Hemostatic & Tissue Sealants-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1835292

No of Pages : 115

Synopsis
Hemostatic agents and tissue sealants are used routinely to prevent excess blood loss and in reconstruction during surgical repair. Some of the available products include thrombin sealant, fibrin glue, bovine serum/albumin/glutaraldehyde, and gelatin matrix.
The global Hemostatic & Tissue Sealants market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hemostatic & Tissue Sealants in various end use industries. The expanding demands from the Minimally Invasive Surgery, General Surgery and Other, are propelling Hemostatic & Tissue Sealants market. Hemostatic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tissue Sealants segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostatic & Tissue Sealants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hemostatic & Tissue Sealants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hemostatic & Tissue Sealants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostatic & Tissue Sealants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hemostatic & Tissue Sealants covered in this report include JandJ, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer and CSL Behring, etc.
The global Hemostatic & Tissue Sealants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
JandJ
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith and Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
Global Hemostatic & Tissue Sealants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hemostatic & Tissue Sealants market, Segment by Type:
Hemostatic
Tissue Sealants
Global Hemostatic & Tissue Sealants market, by Application
Minimally Invasive Surgery
General Surgery
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hemostatic & Tissue Sealants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hemostatic & Tissue Sealants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Hemostatic & Tissue Sealants Market Overview
1.1 Hemostatic & Tissue Sealants Product Overview
1.2 Hemostatic & Tissue Sealants Market Segment by Type
1.2.1 Hemostatic
1.2.2 Tissue Sealants
1.3 Global Hemostatic & Tissue Sealants Market Size by Type
1.3.1 Global Hemostatic & Tissue Sealants Market Size Overview by Type (2018-2029)
1.3.2 Global Hemostatic & Tissue Sealants Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hemostatic & Tissue Sealants Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hemostatic & Tissue Sealants Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hemostatic & Tissue Sealants Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hemostatic & Tissue Sealants Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hemostatic & Tissue Sealants Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hemostatic & Tissue Sealants Sales Breakdown by Type (2018-2023)
2 Global Hemostatic & Tissue Sealants Market Competition by Company
2.1 Global Top Players by Hemostatic & Tissue Sealants Sales (2018-2023)
2.2 Global Top Players by Hemostatic & Tissue Sealants Revenue (2018-2023)
2.3 Global Top Players by Hemostatic & Tissue Sealants Price (2018-2023)
2.4 Global Top Manufacturers Hemostatic & Tissue Sealants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hemostatic & Tissue Sealants Market Competitive Situation and Trends
2.5.1 Hemostatic & Tissue Sealants Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hemostatic & Tissue Sealants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostatic & Tissue Sealants as of 2022)
2.7 Date of Key Manufacturers Enter into Hemostatic & Tissue Sealants Market
2.8 Key Manufacturers Hemostatic & Tissue Sealants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hemostatic & Tissue Sealants Status and Outlook by Region
3.1 Global Hemostatic & Tissue Sealants Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hemostatic & Tissue Sealants Historic Market Size by Region
3.2.1 Global Hemostatic & Tissue Sealants Sales in Volume by Region (2018-2023)
3.2.2 Global Hemostatic & Tissue Sealants Sales in Value by Region (2018-2023)
3.2.3 Global Hemostatic & Tissue Sealants Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hemostatic & Tissue Sealants Forecasted Market Size by Region
3.3.1 Global Hemostatic & Tissue Sealants Sales in Volume by Region (2024-2029)
3.3.2 Global Hemostatic & Tissue Sealants Sales in Value by Region (2024-2029)
3.3.3 Global Hemostatic & Tissue Sealants Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hemostatic & Tissue Sealants by Application
4.1 Hemostatic & Tissue Sealants Market Segment by Application
4.1.1 Minimally Invasive Surgery
4.1.2 General Surgery
4.1.3 Other
4.2 Global Hemostatic & Tissue Sealants Market Size by Application
4.2.1 Global Hemostatic & Tissue Sealants Market Size Overview by Application (2018-2029)
4.2.2 Global Hemostatic & Tissue Sealants Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hemostatic & Tissue Sealants Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hemostatic & Tissue Sealants Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hemostatic & Tissue Sealants Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hemostatic & Tissue Sealants Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hemostatic & Tissue Sealants Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hemostatic & Tissue Sealants Sales Breakdown by Application (2018-2023)
5 North America Hemostatic & Tissue Sealants by Country
5.1 North America Hemostatic & Tissue Sealants Historic Market Size by Country
5.1.1 North America Hemostatic & Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hemostatic & Tissue Sealants Sales in Volume by Country (2018-2023)
5.1.3 North America Hemostatic & Tissue Sealants Sales in Value by Country (2018-2023)
5.2 North America Hemostatic & Tissue Sealants Forecasted Market Size by Country
5.2.1 North America Hemostatic & Tissue Sealants Sales in Volume by Country (2024-2029)
5.2.2 North America Hemostatic & Tissue Sealants Sales in Value by Country (2024-2029)
6 Europe Hemostatic & Tissue Sealants by Country
6.1 Europe Hemostatic & Tissue Sealants Historic Market Size by Country
6.1.1 Europe Hemostatic & Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hemostatic & Tissue Sealants Sales in Volume by Country (2018-2023)
6.1.3 Europe Hemostatic & Tissue Sealants Sales in Value by Country (2018-2023)
6.2 Europe Hemostatic & Tissue Sealants Forecasted Market Size by Country
6.2.1 Europe Hemostatic & Tissue Sealants Sales in Volume by Country (2024-2029)
6.2.2 Europe Hemostatic & Tissue Sealants Sales in Value by Country (2024-2029)
7 Asia-Pacific Hemostatic & Tissue Sealants by Region
7.1 Asia-Pacific Hemostatic & Tissue Sealants Historic Market Size by Region
7.1.1 Asia-Pacific Hemostatic & Tissue Sealants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hemostatic & Tissue Sealants Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hemostatic & Tissue Sealants Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hemostatic & Tissue Sealants Forecasted Market Size by Region
7.2.1 Asia-Pacific Hemostatic & Tissue Sealants Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hemostatic & Tissue Sealants Sales in Value by Region (2024-2029)
8 Latin America Hemostatic & Tissue Sealants by Country
8.1 Latin America Hemostatic & Tissue Sealants Historic Market Size by Country
8.1.1 Latin America Hemostatic & Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hemostatic & Tissue Sealants Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hemostatic & Tissue Sealants Sales in Value by Country (2018-2023)
8.2 Latin America Hemostatic & Tissue Sealants Forecasted Market Size by Country
8.2.1 Latin America Hemostatic & Tissue Sealants Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hemostatic & Tissue Sealants Sales in Value by Country (2024-2029)
9 Middle East and Africa Hemostatic & Tissue Sealants by Country
9.1 Middle East and Africa Hemostatic & Tissue Sealants Historic Market Size by Country
9.1.1 Middle East and Africa Hemostatic & Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hemostatic & Tissue Sealants Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hemostatic & Tissue Sealants Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hemostatic & Tissue Sealants Forecasted Market Size by Country
9.2.1 Middle East and Africa Hemostatic & Tissue Sealants Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hemostatic & Tissue Sealants Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 JandJ
10.1.1 JandJ Company Information
10.1.2 JandJ Introduction and Business Overview
10.1.3 JandJ Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.1.4 JandJ Hemostatic & Tissue Sealants Products Offered
10.1.5 JandJ Recent Development
10.2 Baxter
10.2.1 Baxter Company Information
10.2.2 Baxter Introduction and Business Overview
10.2.3 Baxter Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter Hemostatic & Tissue Sealants Products Offered
10.2.5 Baxter Recent Development
10.3 C R Bard
10.3.1 C R Bard Company Information
10.3.2 C R Bard Introduction and Business Overview
10.3.3 C R Bard Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.3.4 C R Bard Hemostatic & Tissue Sealants Products Offered
10.3.5 C R Bard Recent Development
10.4 B Braun
10.4.1 B Braun Company Information
10.4.2 B Braun Introduction and Business Overview
10.4.3 B Braun Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.4.4 B Braun Hemostatic & Tissue Sealants Products Offered
10.4.5 B Braun Recent Development
10.5 Gelita
10.5.1 Gelita Company Information
10.5.2 Gelita Introduction and Business Overview
10.5.3 Gelita Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Gelita Hemostatic & Tissue Sealants Products Offered
10.5.5 Gelita Recent Development
10.6 Integra Life Sciences
10.6.1 Integra Life Sciences Company Information
10.6.2 Integra Life Sciences Introduction and Business Overview
10.6.3 Integra Life Sciences Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Integra Life Sciences Hemostatic & Tissue Sealants Products Offered
10.6.5 Integra Life Sciences Recent Development
10.7 Advance Medical Solution
10.7.1 Advance Medical Solution Company Information
10.7.2 Advance Medical Solution Introduction and Business Overview
10.7.3 Advance Medical Solution Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Advance Medical Solution Hemostatic & Tissue Sealants Products Offered
10.7.5 Advance Medical Solution Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Hemostatic & Tissue Sealants Products Offered
10.8.5 Pfizer Recent Development
10.9 CSL Behring
10.9.1 CSL Behring Company Information
10.9.2 CSL Behring Introduction and Business Overview
10.9.3 CSL Behring Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.9.4 CSL Behring Hemostatic & Tissue Sealants Products Offered
10.9.5 CSL Behring Recent Development
10.10 CryoLife
10.10.1 CryoLife Company Information
10.10.2 CryoLife Introduction and Business Overview
10.10.3 CryoLife Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CryoLife Hemostatic & Tissue Sealants Products Offered
10.10.5 CryoLife Recent Development
10.11 Zimmer Biomet
10.11.1 Zimmer Biomet Company Information
10.11.2 Zimmer Biomet Introduction and Business Overview
10.11.3 Zimmer Biomet Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Zimmer Biomet Hemostatic & Tissue Sealants Products Offered
10.11.5 Zimmer Biomet Recent Development
10.12 Ferrosan Medical Devices
10.12.1 Ferrosan Medical Devices Company Information
10.12.2 Ferrosan Medical Devices Introduction and Business Overview
10.12.3 Ferrosan Medical Devices Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Ferrosan Medical Devices Hemostatic & Tissue Sealants Products Offered
10.12.5 Ferrosan Medical Devices Recent Development
10.13 Medtronic
10.13.1 Medtronic Company Information
10.13.2 Medtronic Introduction and Business Overview
10.13.3 Medtronic Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Medtronic Hemostatic & Tissue Sealants Products Offered
10.13.5 Medtronic Recent Development
10.14 Smith and Nephew
10.14.1 Smith and Nephew Company Information
10.14.2 Smith and Nephew Introduction and Business Overview
10.14.3 Smith and Nephew Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Smith and Nephew Hemostatic & Tissue Sealants Products Offered
10.14.5 Smith and Nephew Recent Development
10.15 Z-Medica
10.15.1 Z-Medica Company Information
10.15.2 Z-Medica Introduction and Business Overview
10.15.3 Z-Medica Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Z-Medica Hemostatic & Tissue Sealants Products Offered
10.15.5 Z-Medica Recent Development
10.16 Cohera Medical
10.16.1 Cohera Medical Company Information
10.16.2 Cohera Medical Introduction and Business Overview
10.16.3 Cohera Medical Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Cohera Medical Hemostatic & Tissue Sealants Products Offered
10.16.5 Cohera Medical Recent Development
10.17 Marine Polymer
10.17.1 Marine Polymer Company Information
10.17.2 Marine Polymer Introduction and Business Overview
10.17.3 Marine Polymer Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Marine Polymer Hemostatic & Tissue Sealants Products Offered
10.17.5 Marine Polymer Recent Development
10.18 Equimedical
10.18.1 Equimedical Company Information
10.18.2 Equimedical Introduction and Business Overview
10.18.3 Equimedical Hemostatic & Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Equimedical Hemostatic & Tissue Sealants Products Offered
10.18.5 Equimedical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hemostatic & Tissue Sealants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hemostatic & Tissue Sealants Industrial Chain Analysis
11.4 Hemostatic & Tissue Sealants Market Dynamics
11.4.1 Hemostatic & Tissue Sealants Industry Trends
11.4.2 Hemostatic & Tissue Sealants Market Drivers
11.4.3 Hemostatic & Tissue Sealants Market Challenges
11.4.4 Hemostatic & Tissue Sealants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hemostatic & Tissue Sealants Distributors
12.3 Hemostatic & Tissue Sealants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’